Literature DB >> 24804174

Radiotherapeutic options for hepatocellular carcinoma with portal vein tumor thrombosis.

Dong Soo Lee1, Jinsil Seong1.   

Abstract

Portal vein tumor thrombosis (PVTT) is a common paraneoplastic condition in advanced primary hepatocellular carcinoma or hepatobiliary tract malignancies. Tumors with PVTT are frequently associated with adverse and aggressive features such as intrahepatic tumor dissemination, early treatment failure, or deterioration of hepatic function. Therefore, the treatment outcomes for PVTT in historical series are often dismal and discouraging. More recently, beneficial effects and excellent outcomes of external beam radiation therapy (EBRT) for treating this disease have been reported, and the use of EBRT is becoming more common because of the non-invasive nature of RT and rapid advances in RT technology. We hope to be able to cure this devastating condition in the near future with more advanced and efficacious disease management strategies. The current status and clinical trial results for EBRT as a promising treatment option for managing PVTT will be discussed here.

Entities:  

Keywords:  Hepatocellular carcinoma; Portal vein tumor thrombosis; Radiotherapy

Year:  2014        PMID: 24804174      PMCID: PMC3995383          DOI: 10.1159/000343855

Source DB:  PubMed          Journal:  Liver Cancer        ISSN: 1664-5553            Impact factor:   11.740


  55 in total

Review 1.  Partial volume tolerance of the liver to radiation.

Authors:  Laura A Dawson; Randall K Ten Haken
Journal:  Semin Radiat Oncol       Date:  2005-10       Impact factor: 5.934

2.  Multimodality treatment in hepatocellular carcinoma patients with tumor thrombi in portal vein.

Authors:  J Fan; Z Q Wu; Z Y Tang; J Zhou; S J Qiu; Z C Ma; X D Zhou; S L Ye
Journal:  World J Gastroenterol       Date:  2001-02       Impact factor: 5.742

Review 3.  Proton-beam therapy for prostate cancer.

Authors:  A Robert Kagan; Robert J Schulz
Journal:  Cancer J       Date:  2010 Sep-Oct       Impact factor: 3.360

4.  Effects of location and extension of portal vein tumor thrombus on long-term outcomes of surgical treatment for hepatocellular carcinoma.

Authors:  Xiao-Ping Chen; Fa-Zu Qiu; Zai-De Wu; Zhi-Wei Zhang; Zhi-Yong Huang; Yi-Fa Chen; Bi-Xiang Zhang; Song-Qing He; Wan-Guang Zhang
Journal:  Ann Surg Oncol       Date:  2006-05-23       Impact factor: 5.344

5.  Radiotherapy plus transarterial chemoembolization for hepatocellular carcinoma invading the portal vein: long-term patient outcomes.

Authors:  Sang Min Yoon; Young-Suk Lim; Hyung Jin Won; Jong Hoon Kim; Kang Mo Kim; Han Chu Lee; Young-Hwa Chung; Yung Sang Lee; Sung Gyu Lee; Jin-Hong Park; Dong Jin Suh
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-05-27       Impact factor: 7.038

Review 6.  Application of Radiotherapeutic Strategies in the BCLC-Defined Stages of Hepatocellular Carcinoma.

Authors:  Cha Jihye; Seong Jinsil
Journal:  Liver Cancer       Date:  2012-11       Impact factor: 11.740

7.  Proton beam therapy for unresectable malignancies of the nasal cavity and paranasal sinuses.

Authors:  Sadamoto Zenda; Ryosuke Kohno; Mitsuhiko Kawashima; Satoko Arahira; Teiji Nishio; Makoto Tahara; Ryuichi Hayashi; Seiji Kishimoto; Takashi Ogino
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-10-18       Impact factor: 7.038

8.  Applicability of BCLC stage for prognostic stratification in comparison with other staging systems: single centre experience from long-term clinical outcomes of 1717 treatment-naïve patients with hepatocellular carcinoma.

Authors:  Beom Kyung Kim; Seung Up Kim; Jun Yong Park; Do Young Kim; Sang Hoon Ahn; Mi Sung Park; Eun Hye Kim; Jinsil Seong; Do Youn Lee; Kwang-Hyub Han
Journal:  Liver Int       Date:  2012-04-23       Impact factor: 5.828

9.  Complete Metabolic Response with Recanalization of Portal Vein Tumor Thrombosis after Sunitinib in a Patient with Advanced Hepatocellular Carcinoma.

Authors:  Michele Basso; Maria Basso; Alessandro Iaculli; Maurizio Pompili; Laura Riccardi; Brunella Barbaro; Vittoria Rufini; Alessandra Cassano; Paola Castaldi; Carlo Barone
Journal:  Case Rep Oncol       Date:  2010-11-06

10.  Intra-arterial 5-fluorouracil/interferon combination therapy for advanced hepatocellular carcinoma with or without three-dimensional conformal radiotherapy for portal vein tumor thrombosis.

Authors:  Yoshio Katamura; Hiroshi Aikata; Shintaro Takaki; Takahiro Azakami; Tomokazu Kawaoka; Koji Waki; Akira Hiramatsu; Yoshiiku Kawakami; Shoichi Takahashi; Masahiro Kenjo; Naoyuki Toyota; Katsuhide Ito; Kazuaki Chayama
Journal:  J Gastroenterol       Date:  2009-03-28       Impact factor: 7.527

View more
  15 in total

1.  Locoregional Therapy for Hepatocellular Carcinoma.

Authors:  M Kudo
Journal:  Liver Cancer       Date:  2015-06-05       Impact factor: 11.740

2.  Comprehensive treatments for hepatocellular carcinoma with tumor thrombus in major portal vein.

Authors:  Hai-Hong Ye; Jia-Zhou Ye; Zhi-Bo Xie; Yu-Chong Peng; Jie Chen; Liang Ma; Tao Bai; Jun-Ze Chen; Zhan Lu; Hong-Gui Qin; Bang-De Xiang; Le-Qun Li
Journal:  World J Gastroenterol       Date:  2016-04-07       Impact factor: 5.742

3.  Value of dynamic contrast enhanced MRI in predicting outcomes of HCC receiving radiotherapy.

Authors:  Masatoshi Kudo
Journal:  Hepatol Int       Date:  2015-03-07       Impact factor: 6.047

4.  Efficacy of hepatic arterial infusion chemotherapy in combination with irradiation for advanced hepatocellular carcinoma with portal vein invasion.

Authors:  Hideki Onishi; Kazuhiro Nouso; Shinichiro Nakamura; Kuniaki Katsui; Nozomu Wada; Yuki Morimoto; Koji Miyahara; Yasuto Takeuchi; Kenji Kuwaki; Tetsuya Yasunaka; Yasuhiro Miyake; Hidenori Shiraha; Akinobu Takaki; Yoshiyuki Kobayashi; Kohsaku Sakaguchi; Susumu Kanazawa; Kazuhide Yamamoto
Journal:  Hepatol Int       Date:  2014-11-22       Impact factor: 6.047

5.  Hepatic resection versus transarterial chemoembolization for patients with Barcelona Clinic Liver Cancer intermediate stage Child-Pugh A hepatocellular carcinoma.

Authors:  Yin-Nong Zhao; Yong-Quan Zhang; Jia-Zhou Ye; Xing Liu; Hong-Zhi Yang; Feng-Yun Cong; Bang-De Xiang; Fei-Xiang Wu; Liang Ma; Le-Qun Li; Hai-Hong Ye
Journal:  Exp Ther Med       Date:  2016-10-17       Impact factor: 2.447

6.  Endovascular brachytherapy combined with portal vein stenting and transarterial chemoembolization improves overall survival of hepatocellular carcinoma patients with main portal vein tumor thrombus.

Authors:  Tian-Zhu Yu; Wen Zhang; Qing-Xin Liu; Wen-Hui Li; Jing-Qin Ma; Zi-Han Zhang; Min-Jie Yang; Jian-Hua Wang; Bing Chen; Shao-Chong Zeng; Jian-Jun Luo; Ling-Xiao Liu; Zhi-Ping Yan
Journal:  Oncotarget       Date:  2017-02-14

7.  Endovascular brachytherapy combined with stent placement and TACE for treatment of HCC with main portal vein tumor thrombus.

Authors:  Jian-Jun Luo; Zi-Han Zhang; Qing-Xin Liu; Wen Zhang; Jian-Hua Wang; Zhi-Ping Yan
Journal:  Hepatol Int       Date:  2015-09-04       Impact factor: 6.047

8.  Re-Irradiation of Hepatocellular Carcinoma: Clinical Applicability of Deformable Image Registration.

Authors:  Dong Soo Lee; Joong Yeol Woo; Jun Won Kim; Jinsil Seong
Journal:  Yonsei Med J       Date:  2016-01       Impact factor: 2.759

9.  The response of thrombosis in the portal vein or hepatic vein in hepatocellular carcinoma to radiation therapy.

Authors:  Bong Kyung Bae; Jae-Chul Kim
Journal:  Radiat Oncol J       Date:  2016-08-22

Review 10.  Multidisciplinary management of hepatocellular carcinoma with portal vein tumor thrombus - Eastern Hepatobiliary Surgical Hospital consensus statement.

Authors:  Shuqun Cheng; Jiamei Yang; Feng Shen; Weiping Zhou; Yi Wang; Wenming Cong; Guang Shun Yang; Hongyan Cheng; Heping Hu; Chunfang Gao; Jia Guo; Aijun Li; Yan Meng; Xiaoqing Jiang; Yefa Yang; Guojun Qian; Ming Luo; Bing Hu; Xiaobo Man; Baohua Zhang; Changqing Su; Feiguo Zhou; Nan Li; Jie Shi; Meng Wang; Yaxin Zheng; Weixing Guo; Juxian Sun; Hongyang Wang; Wan-Yee Lau; Meng-Chao Wu
Journal:  Oncotarget       Date:  2016-06-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.